Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome.
Belinda GrayAlban-Elouen BaruteauAlbert A AntolinAlan M PittmanGiselle Sarganas MargolisMariam MolokhiaMarieke T BlomRachel BastiaenenAbdenasser BardaiSilvia Giuliana PrioriCarlo NapolitanoPeter E WeekeSaad A ShakirWilhelm HaverkampJordi MestresBo Gregers WinkelAdam A WitneyIrina Chis SterAjanthah SangaralingamAlan John CammJacob Tfelt HansenDan M RodenHanno L TanEdeltraut GarbeMiriam C J M SturkenboomElijah R BehrPublished in: Circulation. Genomic and precision medicine (2022)
Rare susceptibility variants in CYP genes are emerging as potentially important pharmacogenomic risk markers for aLQTS and could form part of personalized medicine approaches in the future.